Robert Maslansky
- Virology top 10%
- HIV Research and Treatment 3
- Infectious Diseases top 10%
- HIV/AIDS Research and Interventions 6
- Epidemiology top 10%
- HIV, Drug Use, Sexual Risk 6
- Substance Abuse Treatment and Outcomes 4
- Toxicology top 10%
- Forensic Toxicology and Drug Analysis 2
-
- Schizophrenia research and treatment 2
-
- Opioid Use Disorder Treatment 5
-
- Mental Health Treatment and Access 3
- Co-authors
- Michael MarmorSamuel R. FriedmanJo L. SotheranDon C. Des JarlaisDonna MildvanD. BenEzraStephen SchultzLeo Gorelkin
- Partner nations
- United StatesSwitzerlandChina
In The Last Decade
Robert Maslansky
17 papers receiving 513 citations
Peers
Comparison fields: 5 of 70
- Virology 68
- Infectious Diseases 213
- Epidemiology 318
- Toxicology 22
- Psychiatry and Mental health 74
Countries citing papers authored by Robert Maslansky
This map shows the geographic impact of Robert Maslansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Maslansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Maslansky more than expected).
Fields of papers citing papers by Robert Maslansky
This network shows the impact of papers produced by Robert Maslansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Maslansky. The network helps show where Robert Maslansky may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Maslansky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 1 | |
| 2 | 2004 | 41 | |
| 3 | 2004 | 65 | |
| 4 | 2003 | 7 | |
| 5 | 1995 | 21 | |
| 6 | 1995 | 3 | |
| 7 | Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs. | 1994 | 10 |
| 8 | 1992 | 40 | |
| 9 | 1992 | 5 | |
| 10 | 1990 | 16 | |
| 11 | 1989 | 21 | |
| 12 | 1988 | 151 | |
| 13 | 1987 | 116 | |
| 14 | 1986 | 64 | |
| 15 | 1978 | 1 | |
| 16 | 1974 | 2 | |
| 17 | 1973 | 2 | |
| 18 | 1970 | 4 |
About Robert Maslansky
Robert Maslansky is a scholar working on Virology, Toxicology and Infectious Diseases, having authored 18 papers that have together received 570 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (6 papers), HIV, Drug Use, Sexual Risk (6 papers), Opioid Use Disorder Treatment (5 papers), Substance Abuse Treatment and Outcomes (4 papers), HIV Research and Treatment (3 papers), Mental Health Treatment and Access (3 papers), Forensic Toxicology and Drug Analysis (2 papers) and Schizophrenia research and treatment (2 papers). The work is most often cited by research in Virology (68 citations), Infectious Diseases (213 citations) and Epidemiology (318 citations). Robert Maslansky has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Michael Marmor, Samuel R. Friedman, Jo L. Sotheran, Don C. Des Jarlais, Donna Mildvan, D. BenEzra, Stephen Schultz, Leo Gorelkin, Rand Stoneburner and Richard I. Levin. Their work appears in journals such as Science, JAMA and American Journal of Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.